• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上消化道疾病患者感染患病率及根除方案有效性分析(基于2006 - 2019年13C - 尿素呼气试验结果)

Analysis of the prevalence of infection and the effectiveness of eradication schemes in patients with the upper gastrointestinal tract disorders (according to the results of 13C-urea breath tests for 2006-2019).

作者信息

Kondratiuk Nataliia, Paliy Iryna, Zaika Serhii

机构信息

Primary Care Centre of Khmelnitskyi District, Khmelnitskyi, Ukraine.

National Pirogov Memorial Medical University, Vinnytsya, Ukraine.

出版信息

Prz Gastroenterol. 2021;16(3):229-234. doi: 10.5114/pg.2021.108976. Epub 2021 Sep 17.

DOI:10.5114/pg.2021.108976
PMID:34584585
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8456768/
Abstract

INTRODUCTION

The problem of is relevant due to the high frequency of stomach and duodenum erosions and ulcers, as well as the possible development of metaplasia and gastric cancer. Therefore, it is especially important to study the dynamics of infection and monitor the effectiveness of eradication schemes in different regions of Ukraine.

AIM

To study the dynamics of infection and to evaluate the effectiveness of eradication schemes in patients with upper gastrointestinal tract disorders - residents of the Vinnytsia region.

MATERIAL AND METHODS

We retrospectively analysed 2205 results of 13C-urea breath tests, performed during 2006-2019 in the National Pirogov Memorial Medical University, Vinnytsya on an infrared analyser.

RESULTS

It was found that patients with upper gastrointestinal tract disorders since 2009 had significantly reduced primary infection. Among the schemes designed according to the Maastricht recommendations, the most effective were as follows: proton pump inhibitor (PPI) + clarithromycin (Clar) + amoxicillin (Amox) - 81.6%, PPI + Clar + Amox + bismuth subcitrate (Bi) - 87%, and PPI + tetracycline (TC) + metronidazole derivatives (MNZ) + Bi - 83.9%. The lowest efficiency was recorded for the scheme PPI + Clar + MNZ, at 68.1%.

CONCLUSIONS

Despite the gradual decrease in infection in the general population, its prevalence remains quite high among the elderly. This dictates that a thorough examination be carried out for patients with disorders of the upper G.I. tract to detect the presence of infection, and if infection is detected, the correct selection of eradication therapy.

摘要

引言

由于胃和十二指肠糜烂及溃疡的高发性,以及化生和胃癌的可能发展,幽门螺杆菌感染问题备受关注。因此,研究乌克兰不同地区幽门螺杆菌感染动态并监测根除方案的有效性尤为重要。

目的

研究维尼察地区上消化道疾病患者幽门螺杆菌感染动态,并评估幽门螺杆菌根除方案的有效性。

材料与方法

我们回顾性分析了2006年至2019年期间在维尼察国立皮罗戈夫纪念医科大学使用红外分析仪进行的2205例¹³C尿素呼气试验结果。

结果

发现自2009年以来,上消化道疾病患者的原发性幽门螺杆菌感染显著减少。根据马斯特里赫特建议设计的方案中,最有效的方案如下:质子泵抑制剂(PPI)+克拉霉素(Clar)+阿莫西林(Amox)——81.6%,PPI+Clar+Amox+枸橼酸铋(Bi)——87%,以及PPI+四环素(TC)+甲硝唑衍生物(MNZ)+Bi——83.9%。PPI+Clar+MNZ方案的效率最低,为68.1%。

结论

尽管普通人群中幽门螺杆菌感染率逐渐下降,但在老年人中其患病率仍然很高。这表明对上消化道疾病患者应进行全面检查以检测幽门螺杆菌感染的存在,若检测到感染,应正确选择根除治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/b898b298cbc6/PG-16-45093-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/b2390ca53ae1/PG-16-45093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/f3acc1aedf44/PG-16-45093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/f004360f61dc/PG-16-45093-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/b898b298cbc6/PG-16-45093-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/b2390ca53ae1/PG-16-45093-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/f3acc1aedf44/PG-16-45093-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/f004360f61dc/PG-16-45093-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19e5/8456768/b898b298cbc6/PG-16-45093-g004.jpg

相似文献

1
Analysis of the prevalence of infection and the effectiveness of eradication schemes in patients with the upper gastrointestinal tract disorders (according to the results of 13C-urea breath tests for 2006-2019).上消化道疾病患者感染患病率及根除方案有效性分析(基于2006 - 2019年13C - 尿素呼气试验结果)
Prz Gastroenterol. 2021;16(3):229-234. doi: 10.5114/pg.2021.108976. Epub 2021 Sep 17.
2
Helicobacter pylori and gastric or duodenal ulcer.幽门螺杆菌与胃或十二指肠溃疡。
Prescrire Int. 2016 Jan;25(167):18-23.
3
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.铋钾柠檬酸胶囊、甲硝唑和四环素三联疗法联合奥美拉唑与克拉霉素三联疗法根除幽门螺杆菌的随机、开放、非劣效性、3 期临床试验。
Lancet. 2011 Mar 12;377(9769):905-13. doi: 10.1016/S0140-6736(11)60020-2. Epub 2011 Feb 21.
4
Optimum duration of regimens for Helicobacter pylori eradication.幽门螺杆菌根除治疗方案的最佳疗程
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
5
New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection.用于治疗幽门螺杆菌感染十二指肠溃疡的新型一周低剂量三联疗法。
Zhonghua Yi Xue Za Zhi (Taipei). 1998 Aug;61(8):448-55.
6
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.大剂量质子泵抑制剂、阿莫西林和强力霉素三联疗法对根除幽门螺杆菌无效:一项概念验证研究。
Helicobacter. 2014 Apr;19(2):90-7. doi: 10.1111/hel.12106. Epub 2014 Feb 10.
7
13C-urea breath test to validate eradication of Helicobacter pylori in an Israeli population.采用13C尿素呼气试验验证以色列人群中幽门螺杆菌的根除情况。
Isr Med Assoc J. 2003 Feb;5(2):98-100.
8
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.基于枸橼酸铋雷尼替丁的三联疗法作为土耳其患者幽门螺杆菌感染的二线治疗方案
J Gastroenterol Hepatol. 2005 Apr;20(4):637-42. doi: 10.1111/j.1440-1746.2005.03801.x.
9
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.汞合金补牙材料对采用联合、四联及基于左氧氟沙星疗法治疗的患者幽门螺杆菌感染发生率及幽门螺杆菌根除率的影响。
Eur J Gastroenterol Hepatol. 2015 Jul;27(7):769-75. doi: 10.1097/MEG.0000000000000372.
10
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.枸橼酸铋雷尼替丁、阿莫西林、克拉霉素和甲硝唑每日两次,仅服用五天根除幽门螺杆菌的高效性。
Helicobacter. 2001 Jun;6(2):157-62. doi: 10.1046/j.1523-5378.2001.00023.x.

引用本文的文献

1
Seroprevalence and Its Associations with Sociodemographic Characteristics, Environmental Factors, and Gastrointestinal Complaints: A Cross-Sectional Study in the Adult Population of Kaunas City, Lithuania.血清阳性率及其与社会人口学特征、环境因素和胃肠道不适的关联:立陶宛考纳斯市成年人口的横断面研究
Medicina (Kaunas). 2025 Jun 6;61(6):1049. doi: 10.3390/medicina61061049.

本文引用的文献

1
Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection.系统评价与荟萃分析:全球幽门螺杆菌感染的流行情况。
Aliment Pharmacol Ther. 2018 Apr;47(7):868-876. doi: 10.1111/apt.14561. Epub 2018 Feb 12.
2
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.
3
[Possibilities for optimization of eradication therapy for Helicobacter pylori infection in modern clinical practice].
[现代临床实践中幽门螺杆菌感染根除治疗的优化可能性]
Ter Arkh. 2017;89(2):84-90. doi: 10.17116/terarkh201789284-90.
4
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.美国胃肠病学会临床指南:幽门螺杆菌感染的治疗
Am J Gastroenterol. 2017 Feb;112(2):212-239. doi: 10.1038/ajg.2016.563. Epub 2017 Jan 10.
5
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.幽门螺杆菌感染的管理——马斯特里赫特 V/佛罗伦萨共识报告。
Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.
6
Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.系统评价与荟萃分析:质子泵抑制剂、阿莫西林和甲硝唑三联疗法用于幽门螺杆菌一线治疗
J Antimicrob Chemother. 2016 Oct;71(10):2740-53. doi: 10.1093/jac/dkw220. Epub 2016 Jun 23.
7
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.《多伦多成人幽门螺杆菌感染治疗共识》。
Gastroenterology. 2016 Jul;151(1):51-69.e14. doi: 10.1053/j.gastro.2016.04.006. Epub 2016 Apr 19.
8
[EPIDEMIOLOGICAL STUDIES IN GASTROENTEROLOGY: LONG-TERM SIBERIAN EXPERIENCE OF HELICOBACTER PYLORI AND RELATED DISEASES].
Eksp Klin Gastroenterol. 2015(3):4-10.
9
Sequential Therapy or Standard Triple Therapy for Helicobacter pylori Infection: An Updated Systematic Review.幽门螺杆菌感染的序贯疗法或标准三联疗法:一项更新的系统评价
Am J Ther. 2016 May-Jun;23(3):e880-93. doi: 10.1097/MJT.0000000000000191.
10
Helicobacter pylori: perspectives and time trends.幽门螺杆菌:展望与时间趋势。
Nat Rev Gastroenterol Hepatol. 2014 Oct;11(10):628-38. doi: 10.1038/nrgastro.2014.99. Epub 2014 Jul 8.